Skip to main content
SpringerLink
Log in

Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

In the scope of a prospective multi-centre study after neoadjuvant combined chemotherapy (carboplatin, ifosfamide, etoposide, vindesine) and radiotherapy (45 Gy) 40 resection specimens of locally advanced non-small-cell lung cancer were analysed in order to establish reproducible pathological/anatomical results of tumour regression. Resection specimens of 28 squamous cell carcinomas and 12 adenocarcinomas were investigated using serial sections of the primary lesion. The mean age of the patients was 57 years. The results were compared to spontaneous regressive changes in a control group of 50 untreated non-small-cell lung cancers. Marked scarry fibrosis in the region of the former primary tumour, concentric foci of fresh tumour necroses and surrounding foam cell clusters with transition into vascular granulation tissue could be established as characteristic features of therapy-induced tumour regression, whereas untreated carcinomas revealed necroses with adjoining vital tumour tissue. Using a threestep regression system, 3 tumours could be classified as grade I (no or only slight tumour regression), 10 tumours as grade IIA (marked but incomplete tumour regression, more than 10% vital tumour tissue), 20 tumours as grade IIB (less than 10% vital tumour tissue) and 7 tumours as grade III (complete tumour regression without vital tumour tissue). After a median follow-up period of 32.3 months in patients with grade IIB or III tumour regression (“responders”) the median survival time of 27.9 months was found to be significantly longer than in patients with grade I or IIA tumour regression (“non-responders”) with a median survival period of 13.7 months (log-rank test,P=0.020). The resection specimens analysed, which were obtained 7 weeks (on average) after the end of radiochemotherapy, did not show specific changes due to preoperative therapy, but quite characteristic histological alterations in the former tumour area were registered, which had been induced by combined neoadjuvant radiation and chemotherapy. The grade of therapy-induced tumour regression could be shown to be a significant prognostic factor in non-small-cell lung cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Al-Kourainy, Kish J, Ensley J, Tapazoglou E, Jacobs J, Weaver A, Crissman J, Cummings G, Al-Sarraf (1987) Achievement of superior survival for histologically negative versus positive clinically complete responders to cisplatin combination in patients with locally advanced head and neck cancer. Cancer 59:233–238

    PubMed  Google Scholar 

  • Becker K, Fink U, Siewert JR, Höfler H (1996) Morphological effects of preoperative chemotherapy in locally advanced adenocarcinoma of the stomach (T3/T4) with EAP (etoposid, Adriamycin, cis-platin). Pathol Res Pract 192:341

    Google Scholar 

  • Böheim K, Mikuz G, Böheim C (1982) Pathohistologische Veränderungen nach zytostatischer Induktionstherapie mit Methotrexat, Bleomycin und Cis-Platinum. Laryngol Rhinol Otol 61:246–250

    Google Scholar 

  • Bromley LL, Szur L (1955) Combined radiotherapy and resection for carcinoma of the bronchus. Lancet 1955:937–941

    Google Scholar 

  • Burkes RL, Ginsberg RJ, Shepherd FA (1992) Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small cell lung cancer: results of the Toronto phase II trial. J Clin Oncol 10:580–586

    PubMed  Google Scholar 

  • Dabbs DJ (1993) Mammary ductal foam cells: macrophage immunophenotype. Hum Pathol 24:977–981

    PubMed  Google Scholar 

  • Dhom G, Degro S (1982) Therapy of prostatic cancer and histopathologic follow-up. Prostate 3:531–542

    PubMed  Google Scholar 

  • Eagan R, Ruud C, Lee R (1987) Pilot study of induction therapy with cyclophosphamide, doxorubicin, and cisplatin (CAP) and chest irradiation prior to thoracotomy in initially inoperable stage III M0 non-small cell lung cancer. Cancer Treat Rep 71:895–900

    PubMed  Google Scholar 

  • Edelmann MJ, Gandara DR, Roach M, Benfield JR (1996) Multimodality therapy in stage III non-small cell lung cancer. Ann Thorac Surg 47:669–675

    Google Scholar 

  • Eiff M von, Geiger A, Wagner W, Rübe C, Klinke V, Thomas M, Loo J van de (1994) Neoadjuvant chemo-/radiotherapy in locally advanced non-small cell lung cancer. In: Rao RS, Deo MG, Sanghvi LD (eds) Proceedings of the 16th International Cancer Congress, Monducci, Bologna 1994. pp 1187–1190

  • Faber LD, Kittle CF, Warren WT (1989) Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer. Ann Thorac Surg 47:669–677

    PubMed  Google Scholar 

  • Fischer HP (1985) Therapieinduzierte Tumorregression — Morphologische Befunde an malignen primären und sekundären Lebertumoren nach hochdosierter regionaler Zytostase. Pathologe 6:16–23

    PubMed  Google Scholar 

  • Gerrity RG (1981) The role of monocyte in atherosclerosis. I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol 103:181–190

    PubMed  Google Scholar 

  • Green S, Weiss GR (1992) Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria. West New Drugs 10:243–253

    Google Scholar 

  • Helpap B, Böcking A, Dhom G, Faul P, Kastendieck H (1985) Klassifikation, histologisches und zytologisches Grading sowie Regressionsgrading des Prostatakarzinoms. Pathologe 6:3–7

    PubMed  Google Scholar 

  • Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and PAP. J Histochem Cytochem 29:577–580

    PubMed  Google Scholar 

  • Huvos AG, Rosen G, Marcove RC (1977) Primary osteogenic osteosarcoma. Arch Pathol Lab Med 101:14–18

    PubMed  Google Scholar 

  • Junker K, Krapp D, Müller KM (1994) Morphological changes in small cell bronchial carcinoma after neoadjuvant chemotherapy. In: Antypas G (ed) Proceedings of the 16th International Cancer Congress, Monducci, Bologna, 1994. pp 133–136

  • Junker K, Krapp D, Müller KM (1995) Kleinzelliges Bronchialkarzinom nach Chemotherapie — Morphologische Befnde. Pathologe 16:217–222

    PubMed  Google Scholar 

  • Kaplan EL, Meier P (1958) Non-parametrics estimation from incomplete observations. J Am Statist Assoc 53:457–481

    Google Scholar 

  • Klurfeld DM (1985) Identification of foam cells in human atherosclerotic lesions as macrophages using monoclonal antibodies. Arch Pathol Lab Med 109:445–449

    PubMed  Google Scholar 

  • Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Petiot JF, Roussel A, Jacob JH, Segol P, Samama G, Ollivier JM, Bonvalot S, Gignoux M (1994) Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Cancer 73:2680–2686

    PubMed  Google Scholar 

  • Mould RF, Williams RJ (1982) Survival of histologically proven carcinoma of the lung registered in the North-West-Thames region. Br J Cancer 40:999–1003

    Google Scholar 

  • Mountain CF (1986) A new international staging system for lung cancer. Chest [Suppl] 89:225s-232s

    PubMed  Google Scholar 

  • Mountain CF (1994) Surgery for stage IIIa-N2 non-small cell lung cancer. Cancer 73:2589–2598

    PubMed  Google Scholar 

  • Müller KM, Junker K, Wiethege T (1995) Nichtkleinzellige Bronchialkarzinome — Morphologie, Tumorregression, Molekularpatholgie. Onkologe 1:429–440

    Google Scholar 

  • Picci P, Bacci G, Campanacci M, Gasparini M, Pilotti S, Cerasoli S, Bertoni F, Guerra A, Capanna R, Albisinni U, Galletti S, Gherlinzoni F, Calderoni P, Sudanese A, Baldini N, Bernini M Jaffe N (1985) Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy. Cancer 56:1515–1521

    PubMed  Google Scholar 

  • Pisters KMW, Kris MG, Gralla RJ (1990) Preoperative chemotherapy in stage IIIA non-small cell lung cancer: an analysis of a trial in patients with clinically apparent mediastinal node involvement. In: Salmon SE (ed) Adjuvant therapy of cancer. Saunders, Philadelphia, pp 133–137

    Google Scholar 

  • Pisters KMW, Kris MG, Gralla RJ, Zaman MB, Heelan RT, Martini N (1993) Pathologic complete response in advanced non-small cell lung cancer following preoperative chemotherapy: implications for the design of future non-small cell lung cancer combined modality trials. J Clin Oncol 11:1757–1762

    PubMed  Google Scholar 

  • Roessner A, Krüger KH, Ritter J, Urbanitz D (1986) Zur Morphologie des Ewing-Sarkoms nach primärer Chemotherapie. GBK-Mitteilungsdienst 49:28–33

    Google Scholar 

  • Rosell R, Gomez-Codina J, Camps C, Maestre J, Padille J, Canto A, Mate JL, Li S, Roig J (1994) A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 330:153–158

    PubMed  Google Scholar 

  • Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, Marcove RC, Lane JM, Mehta B, Urban C (1982) Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of tumor to preoperative chemotherapy. Cancer 49:1221–1230

    PubMed  Google Scholar 

  • Roth JA, Fossella F, Komaki R, Ryan MB, Putnam JB, Lee JS, Dhingra H, De Caro L, Chasen M, McGavran M, Atkinson EN, Hong WK (1994) A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. J Natl Cancer Inst 86:673–680

    PubMed  Google Scholar 

  • Rusch VW (1993) Neoadjuvant chemotherapy for stage III lung cancer. Semin Thorac Cardiovasc Surg 5:258–267

    PubMed  Google Scholar 

  • Salzer-Kuntschik M, Brand G, Delling G (1983) Bestimmung des morphologischen Regressionsgrades nach Chemotherapie bei malignen Knochentumoren. Pathologe 4:135–141

    PubMed  Google Scholar 

  • Schaffner T, Taylor K, Bartucci EJ (1980) Arterial foam cells with distinctive immunomorphologic and histologic features of macrophages. Am J Pathol 100:57–80

    PubMed  Google Scholar 

  • Sherman D, Strauss G, Schwartz J (1987) Combined modality therapy for regionally advanced stage III non-small cell carcinoma of the lung (NSCLC) employing neo-adjuvant chemotherapy (CT), radiotherapy (RT), and surgery (S). Proc Am Soc Clin Oncol 6:167

    Google Scholar 

  • Shields TW, Higgins GA, Lawton R (1970) Preoperative X-ray therapy as an adjuvant in the treatment of bronchogenic carcinoma. J Thorac Carciovasc Surg 59:49–61

    Google Scholar 

  • Skarin A, Jochelson M, Sheldon T (1989) Neoadjuvant chemotherapy in marginally resectable stage III M0 non-small cell lung cancer: long-term follow-up in 41 patients. J Surg Oncol 40:266–274

    PubMed  Google Scholar 

  • Strauss G, Sherman L, Mathisen D (1988) Concurrent chemotherapy (CT) and radiotherapy (RT) followed by surgery (S) in marginally resectable stage III non-small cell carcinoma of the lung (NSCLC): a Cancer and Leukemia Group B study. Proc Am Soc Clin Oncol 7:203

    Google Scholar 

  • Sulfaro S, Frustaci S, Volpe R, Barzan L, Comoretto R, Monfardini S, Carbone A (1989) A pathologic assessment of tumor residue and stromal changes after intraarterial chemotherapy for head and neck carcinomas. Cancer 64:994–1001

    PubMed  Google Scholar 

  • Thomas M, Macha HN, Rübe C, Loo J van de (1995) Stellenwert der Chemotherapie in der multimodalen Behandlung des nichtkleinzelligen Bronchialkarzinoms. Dtsch Med Wochenschr 120:1627–1630

    PubMed  Google Scholar 

  • Thomas M, Eiff M von, Rübe C, Klinke V, Diederich S, Loo J van de (1996) Erfolgreiche multimodale Behandlung eines lokal weit fortgeschrittenen nicht-kleinzelligen Bronchialkarzinoms. Dtsch Med Wochenschr 121:658–662

    PubMed  Google Scholar 

  • Weiden P, Piantadosi S (1988) Preoperative Chemoradiotherapy in stage III non-small cell lung cancer (NSCLC): A phase II study of the lung cancer study group (LCSG). Proc Am Soc Clin Oncol 7:197

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Pathology, Bergmannsheil-University Hospital, Bürkle-de-la-Camp-Platz 1, 44789, Bochum, Germany

    K. Junker, K. Schulmann & K. -M. Müller

  2. Department of Internal Medicine A, University Hospital, Münster, Germany

    M. Thomas

  3. Department of Thoracic Surgery, St. Elisabeth Hospital, Ibbenbüren, Germany

    F. Klinke

  4. Institute of Pathology, Osnabrück, Germany

    U. Bosse

Authors
  1. K. Junker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Schulmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. Klinke
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. U. Bosse
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. -M. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Junker, K., Thomas, M., Schulmann, K. et al. Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment. J Cancer Res Clin Oncol 123, 469–477 (1997). https://doi.org/10.1007/BF01192200

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01192200

Key words

Search

Navigation